Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Brian J. Czerniecki, Colin Snyder et al.|Molecular Therapy|2021Cited by 56
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the ResponseKrithika N. Kodumudi, Brian J. Czerniecki, Ganesan Ramamoorthi et al.|Frontiers in Immunology|2019Cited by 55
Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivoJie Zhao, Zheng Jian-quan, Xiaoli Wei et al.|European Journal of Pharmacology|2007Cited by 41
Dynamin-related protein 1 is involved in micheliolide-induced breast cancer cell deathYongsheng Jia, Chen Wang|OncoTargets and Therapy|2015Cited by 25